Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week

AstraZeneca

Status: Completed

Conditions: Healthy

Study type: Observational

Funder types: Industry

Identifiers

NCT01308372

NIS-CFR-XXX-2011/1

Details and patient eligibility

About

The purpose of this study is to evaluate the proportion of patients which present a high cardiovascular risk estimated by the SCORE scale, in general practice consultations of the 7 French regions (Paris area, North-East, Paris basin, West, South-West, South- East, Mediterranean area)

Full description

MC MD

Enrollment: 9,246 patients

Sex: All

Ages: 50+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Without any personal history of coronary disease
• Non treated with lipid-lowering agents
• Lipid test = 1 year old
• Presenting at least one cardiovascular risk
• Visiting their General Practitioner

Exclusion Criteria:

Trial design

9,246 participants in 1 patient group

1

Description:

For this group of patients, the cardiovascular risk will be evaluated by several tools: the SCORE scale, the Framingham 2008 scale d'Agostino and the 1998 scale Wilson ;